Lothar Seefried

32PUBLICATIONS
119CO-AUTHORS
Paediatrics not elsewhere classifiedPredictive and prognostic markersPharmaceutical delivery technologiesMolecular targetsToxicology (incl. clinical toxicology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (32)

|Jul 05, 2026
Ossification of the Posterior Longitudinal Ligament - Novel findings from Pandora's box of ENPP1 Deficiency.

|Mar 25, 2026
Phase 3 study comparing the efficacy and safety of proposed biosimilar RGB-14-P with denosumab in postmenopausal women with osteoporosis: results from the transition (switch) phase.

Serge Ferrari, Lothar Seefried, Dénes Páll

|Feb 18, 2026
A Randomized Phase 1 Study Comparing the PK, PD, Safety, and Immunogenicity of Proposed Biosimilar RGB-14-X and Denosumab in Healthy Adult Males.

Emmanuel Biver, Jean-Jacques Body, Ashwin Sachdeva

|Dec 11, 2025
A randomized Phase 1b trial evaluating the pharmacodynamics of ilofotase alfa in adults with hypophosphatasia.

Lothar Seefried, Juliane Bernholz, Maarten Kraan

|Oct 03, 2025
Biochemical phenotype of hypophosphatasia in asymptomatic individuals carrying ALPL variants.

Rodrigo Montero-Lopez, Mariam R Farman, Florian Högler

Pageof 6